Trial intelligence / Profile preview

Compound lidocaine cream for prevention of postoperative sore throat under different endotracheal cuff pressures

ChiCTR1900023223Phase 4Not yet recruiting

Sponsor
Zhongda Hospital, Southeast University
Start
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of lidocaine in Post-extubation sore throat (POST) (4 arms), sponsored by Zhongda Hospital, Southeast University. Primary endpoints: postoperative sore throat, postoperative hoarseness and 1 more. Planned start Jun 2019; status: not yet recruiting.

02

Drugs

lidocaine
03

Conditions

Post-extubation sore throat (POST)

Beyond the preview

Go deeper on ChiCTR1900023223.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900023223.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call